Drugs · acquisition-cost intelligence
KLOXXADO
Naloxone HCL· ingredient naloxonePeripheral opioid receptor antagonists· NALOXONE HYDROCHLORIDE 8 mg/.1mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$59.75
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other naloxone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Pentazocine and naloxone | $2.02 | −$57.73 |
| Naloxone Hydrochloride | $4.38 | −$55.37 |
| Naloxone Hydrochloride | $4.38 | −$55.37 |
| naloxone hydrochloride | $13.43 | −$46.31 |
| Naloxone Hydrochloride | $17.66 | −$42.09 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.